177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Name: 177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial
Published: 2026
License: Public Domain

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

prostate-cancer

prostate cancer, prostate cancer patients, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Related documents